N@N

Goldman Scarlato & Karon, P.C. Announces Investigation of Gentiva Health Services, Inc.

_{//health-fitness.news-articles.net/content/2010/ .. nvestigation-of-gentiva-health-services-inc.html}
^{Published in Health and Fitness on Tuesday, December 14th 2010 at 11:20 GMT by Market Wire}  

CONSHOHOCKEN, Pa.--([ BUSINESS WIRE ])--Goldman Scarlato & Karon, P.C. (aGSKa) has commenced an investigation into Gentiva Health Services, Inc. (aGentivaa or the aCompanya)(Nasdaq:GTIV) to determine whether the Company violated federal securities laws by making false statements regarding its business operations and compliance with federal regulations.

On May 12, 2010, the United States Senate Finance Committee requested information from Gentiva regarding its Medicare utilization rates and amount of therapy services furnished to each beneficiary. On May 26, 2010 the Senate Finance Committee requested supplemental information relating to Gentivaa�s compliance program, policies and procedures and billing manuals. On July 13, 2010, the Company revealed that the U.S. Securities and Exchange Commission had commenced a similar investigation and had served a subpoena seeking documents going back to 2000.

What You May Do

If you have information that would assist GSK in its investigation or would like to discuss your legal rights, you may, without obligation or cost to you, e-mail or call Mark S. Goldman, Esq. (888) 668-4130. GSK also encourages anyone with information regarding Gentivaa�s conduct during the period from July 31, 2008 to July 20, 2010 to contact the Firm, including whistleblowers, former employees, shareholders, and others.

About Goldman Scarlato & Karon, P.C.

GSK prosecutes securities fraud, consumer fraud, price-fixing, ERISA class actions, and shareholder-derivative litigation throughout the United States. The Firma�s lawyers have recovered hundreds of millions of dollars on behalf of consumers, investors, and businesses.

To learn more about Goldman Scarlato, please visit our website,[ www.gsk-law.com ].